{"abnormal faeces": 2.47, "acute macular neuroretinopathy": 2.73, "administration site erythema": 4.2, "administration site oedema": 4.91, "administration site pain": 5.56, "administration site reaction": 2.22, "antibody test": 17.18, "antibody test abnormal": 2.73, "antibody test negative": 2.79, "aortic thrombosis": 2.14, "application site oedema": 2.25, "arthralgia": 2.1, "blood fibrinogen increased": 3.24, "blood pressure measurement": 2.09, "body temperature": 2.91, "body temperature abnormal": 2.83, "body temperature increased": 4.81, "body temperature normal": 8.62, "bone pain": 2.38, "capillary fragility": 2.43, "carotid artery thrombosis": 2.26, "cerebral thrombosis": 2.45, "cerebral venous sinus thrombosis": 6.04, "cerebral venous thrombosis": 2.95, "chills": 4.49, "chronic inflammatory demyelinating polyradiculoneuropathy": 2.24, "covid-19": 4.45, "eye haematoma": 3.43, "eye infarction": 2.14, "eyelid bleeding": 2.37, "eyelid haematoma": 2.25, "facial discomfort": 2.49, "feeling cold": 3.09, "feeling hot": 2.31, "feeling of body temperature change": 2.08, "fibrin d dimer": 2.25, "fibrin d dimer increased": 3.48, "guillain-barre syndrome": 3.58, "haemorrhoids thrombosed": 4.52, "head discomfort": 2.08, "headache": 3.1, "hemiparaesthesia": 2.28, "heparin-induced thrombocytopenia test positive": 8.17, "hepatic vein thrombosis": 5.19, "hyperaesthesia": 2.34, "hypotonia": 2.32, "incomplete course of vaccination": 3.41, "influenza": 5.14, "influenza like illness": 4.27, "injection site indentation": 2.01, "injection site joint movement impairment": 2.63, "injection site joint pain": 2.27, "injection site movement impairment": 3.13, "injection site reaction": 4.02, "jugular vein thrombosis": 2.2, "labour pain": 2.08, "limb discomfort": 5.76, "local reaction": 4.05, "locomotive syndrome": 9.49, "mesenteric vein thrombosis": 2.18, "miller fisher syndrome": 2.46, "myalgia": 2.92, "myelin oligodendrocyte glycoprotein antibody-associated disease": 3.6, "myelitis transverse": 2.21, "new daily persistent headache": 2.17, "nuchal rigidity": 2.1, "ocular discomfort": 2.06, "ophthalmic vein thrombosis": 4.47, "oral contusion": 2.09, "oxygen saturation": 6.01, "pain in extremity": 2.56, "pain of skin": 2.0, "peripheral artery thrombosis": 2.67, "peripheral circulatory failure": 2.77, "peripheral vascular disorder": 3.49, "petechiae": 2.78, "phlebitis superficial": 3.04, "polymerase chain reaction positive": 2.21, "portal vein thrombosis": 2.55, "portosplenomesenteric venous thrombosis": 5.62, "pyrexia": 3.67, "respiratory depth decreased": 2.71, "rest regimen": 3.31, "retinal vascular thrombosis": 2.66, "retinal vein thrombosis": 2.19, "reversed hot-cold sensation": 2.9, "sacral pain": 2.32, "sars-cov-2 antibody test": 6.6, "sars-cov-2 antibody test negative": 6.27, "sars-cov-2 test negative": 5.06, "sars-cov-2 test positive": 3.74, "sensory disturbance": 2.17, "sensory level abnormal": 2.46, "severe acute respiratory syndrome": 32.13, "sigmoid sinus thrombosis": 13.91, "splenic vein thrombosis": 2.08, "sudden cardiac death": 2.45, "superficial vein prominence": 4.27, "superficial vein thrombosis": 3.73, "superior sagittal sinus thrombosis": 2.99, "tenderness": 2.14, "thrombophlebitis": 2.7, "thrombosis mesenteric vessel": 2.42, "thrombosis with thrombocytopenia syndrome": 45.63, "transverse sinus thrombosis": 4.27, "vaccination failure": 5.09, "vaccination site atrophy": 7.57, "vaccination site bruising": 2.99, "vaccination site discomfort": 11.91, "vaccination site haematoma": 6.55, "vaccination site hypersensitivity": 6.49, "vaccination site induration": 2.62, "vaccination site injury": 2.44, "vaccination site joint pain": 2.33, "vaccination site movement impairment": 2.13, "vaccination site pain": 2.92, "vaccination site reaction": 2.71, "vaccination site warmth": 2.93, "varicophlebitis": 5.01, "varicose vein": 2.35, "vascular pain": 2.65, "vasodilatation": 2.75, "venous thrombosis": 3.01, "venous thrombosis limb": 2.8, "visceral venous thrombosis": 4.52}